Oct 11, 2013 9:27am EDT Tonix Pharmaceuticals to Participate in the Women's Healthcare Innovation and Leadership Showcase on October 15, 2013
Sep 16, 2013 8:01am EDT Tonix Pharmaceuticals Initiates Enrollment in Phase 2b BESTFIT Trial of TNX-102 SL in Fibromyalgia Patients
Sep 12, 2013 8:00am EDT Tonix Pharmaceuticals to Present at the First Global Life Sciences Conference in Warsaw, Poland on September 17, 2013
Sep 4, 2013 8:00am EDT Tonix Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 9, 2013
Aug 19, 2013 8:00am EDT Tonix Pharmaceuticals Presents Nonclinical Results at the Ninth World Congress on Myofascial Pain Syndrome and Fibromyalgia Syndrome
Aug 9, 2013 8:35am EDT Tonix Pharmaceuticals Announces Pricing of Public Offering of Units and NASDAQ Listing
Mar 11, 2013 7:56am EDT TONIX Completes Pre-Phase 3 Meeting With U.S. Food and Drug Administration for TNX-102 SL in Fibromyalgia
